260 related articles for article (PubMed ID: 11380707)
1. Novel amino acid substitutional mutation, tyrosine-739-aspartic acid, in the androgen receptor gene in complete androgen insensitivity syndrome.
Suzuki K; Fukabori Y; Nakazato H; Hasumi M; Matsui H; Ito K; Kurokawa K; Yamanaka H
Int J Androl; 2001 Jun; 24(3):183-8. PubMed ID: 11380707
[TBL] [Abstract][Full Text] [Related]
2. A substitutional mutation in the DNA binding domain of the androgen receptor causes complete androgen insensitivity syndrome.
Komori S; Sakata K; Kasumi H; Tsuji Y; Hamada K; Koyama K
Gynecol Endocrinol; 1999 Oct; 13(5):327-32. PubMed ID: 10599549
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome.
Ahmed SF; Cheng A; Dovey L; Hawkins JR; Martin H; Rowland J; Shimura N; Tait AD; Hughes IA
J Clin Endocrinol Metab; 2000 Feb; 85(2):658-65. PubMed ID: 10690872
[TBL] [Abstract][Full Text] [Related]
4. Clinical, hormonal and genetic characteristics of androgen insensitivity syndrome in 39 Chinese patients.
Liu Q; Yin X; Li P
Reprod Biol Endocrinol; 2020 Apr; 18(1):34. PubMed ID: 32345305
[TBL] [Abstract][Full Text] [Related]
5. Complete androgen insensitivity syndrome caused by a novel mutation in the ligand-binding domain of the androgen receptor: functional characterization.
Rosa S; Biason-Lauber A; Mongan NP; Navratil F; Schoenle EJ
J Clin Endocrinol Metab; 2002 Sep; 87(9):4378-82. PubMed ID: 12213902
[TBL] [Abstract][Full Text] [Related]
6. Partial androgen insensitivity and correlations with the predicted three dimensional structure of the androgen receptor ligand-binding domain.
Yong EL; Tut TG; Ghadessy FJ; Prins G; Ratnam SS
Mol Cell Endocrinol; 1998 Feb; 137(1):41-50. PubMed ID: 9607727
[TBL] [Abstract][Full Text] [Related]
7. Novel mutation in the ligand-binding domain of the androgen receptor gene (l790p) associated with complete androgen insensitivity syndrome.
Raicu F; Giuliani R; Gatta V; Palka C; Franchi PG; Lelli-Chiesa P; Tumini S; Stuppia L
Asian J Androl; 2008 Jul; 10(4):687-91. PubMed ID: 18097502
[TBL] [Abstract][Full Text] [Related]
8. Partial androgen insensitivity with phenotypic variation caused by androgen receptor mutations that disrupt activation function 2 and the NH(2)- and carboxyl-terminal interaction.
Quigley CA; Tan JA; He B; Zhou ZX; Mebarki F; Morel Y; Forest MG; Chatelain P; Ritzén EM; French FS; Wilson EM
Mech Ageing Dev; 2004; 125(10-11):683-95. PubMed ID: 15541764
[TBL] [Abstract][Full Text] [Related]
9. Androgen insensitivity syndrome: somatic mosaicism of the androgen receptor in seven families and consequences for sex assignment and genetic counseling.
Köhler B; Lumbroso S; Leger J; Audran F; Grau ES; Kurtz F; Pinto G; Salerno M; Semitcheva T; Czernichow P; Sultan C
J Clin Endocrinol Metab; 2005 Jan; 90(1):106-11. PubMed ID: 15522944
[TBL] [Abstract][Full Text] [Related]
10. Discordant measures of androgen-binding kinetics in two mutant androgen receptors causing mild or partial androgen insensitivity, respectively.
Shkolny DL; Beitel LK; Ginsberg J; Pekeles G; Arbour L; Pinsky L; Trifiro MA
J Clin Endocrinol Metab; 1999 Feb; 84(2):805-10. PubMed ID: 10022458
[TBL] [Abstract][Full Text] [Related]
11. Impaired nuclear translocation, nuclear matrix targeting, and intranuclear mobility of mutant androgen receptors carrying amino acid substitutions in the deoxyribonucleic acid-binding domain derived from androgen insensitivity syndrome patients.
Kawate H; Wu Y; Ohnaka K; Tao RH; Nakamura K; Okabe T; Yanase T; Nawata H; Takayanagi R
J Clin Endocrinol Metab; 2005 Nov; 90(11):6162-9. PubMed ID: 16118342
[TBL] [Abstract][Full Text] [Related]
12. Molecular features and clinical phenotypes in androgen insensitivity syndrome in the absence and presence of androgen receptor gene mutations.
Holterhus PM; Werner R; Hoppe U; Bassler J; Korsch E; Ranke MB; Dörr HG; Hiort O
J Mol Med (Berl); 2005 Dec; 83(12):1005-13. PubMed ID: 16283146
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of naturally occurring mutant androgen receptors from subjects with complete androgen insensitivity.
Brown TR; Lubahn DB; Wilson EM; French FS; Migeon CJ; Corden JL
Mol Endocrinol; 1990 Dec; 4(12):1759-72. PubMed ID: 2082179
[TBL] [Abstract][Full Text] [Related]
14. A novel mutation in the human androgen receptor suggests a regulatory role for the hinge region in amino-terminal and carboxy-terminal interactions.
Deeb A; Jääskeläinen J; Dattani M; Whitaker HC; Costigan C; Hughes IA
J Clin Endocrinol Metab; 2008 Oct; 93(10):3691-6. PubMed ID: 18697867
[TBL] [Abstract][Full Text] [Related]
15. The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity.
Ghali SA; Gottlieb B; Lumbroso R; Beitel LK; Elhaji Y; Wu J; Pinsky L; Trifiro MA
J Clin Endocrinol Metab; 2003 May; 88(5):2185-93. PubMed ID: 12727974
[TBL] [Abstract][Full Text] [Related]
16. An androgen receptor mutation in the direct vicinity of the proposed C-terminal alpha-helix of the ligand binding domain containing the AF-2 transcriptional activating function core is associated with complete androgen insensitivity.
Peters I; Weidemann W; Romalo G; Knorr D; Schweikert HU; Spindler KD
Mol Cell Endocrinol; 1999 Feb; 148(1-2):47-53. PubMed ID: 10221770
[TBL] [Abstract][Full Text] [Related]
17. Extreme androgen resistance in a kindred with a novel insertion/deletion mutation in exon 5 of the androgen receptor gene.
Vilchis F; Ramos L; Kofman-Alfaro S; Zenteno JC; Méndez JP; Chávez B
J Hum Genet; 2003; 48(7):346-51. PubMed ID: 12908100
[TBL] [Abstract][Full Text] [Related]
18. A novel point mutation in the hormone binding domain of the androgen receptor associated with partial and minimal androgen insensitivity syndrome.
Galli-Tsinopoulou A; Hiort O; Schuster T; Messer G; Kuhnle U
J Pediatr Endocrinol Metab; 2003 Feb; 16(2):149-54. PubMed ID: 12713250
[TBL] [Abstract][Full Text] [Related]
19. Novel point mutation in the splice donor site of exon-intron junction 6 of the androgen receptor gene in a patient with partial androgen insensitivity syndrome.
Sammarco I; Grimaldi P; Rossi P; Cappa M; Moretti C; Frajese G; Geremia R
J Clin Endocrinol Metab; 2000 Sep; 85(9):3256-61. PubMed ID: 10999818
[TBL] [Abstract][Full Text] [Related]
20. A G577R mutation in the human AR P box results in selective decreases in DNA binding and in partial androgen insensitivity syndrome.
Nguyen D; Steinberg SV; Rouault E; Chagnon S; Gottlieb B; Pinsky L; Trifiro M; Mader S
Mol Endocrinol; 2001 Oct; 15(10):1790-802. PubMed ID: 11579211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
